These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15649103)

  • 1. Appraisal of the MedDRA conceptual structure for describing and grouping adverse drug reactions.
    Bousquet C; Lagier G; Lillo-Le Louët A; Le Beller C; Venot A; Jaulent MC
    Drug Saf; 2005; 28(1):19-34. PubMed ID: 15649103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methods and pitfalls in searching drug safety databases utilising the Medical Dictionary for Regulatory Activities (MedDRA).
    Brown EG
    Drug Saf; 2003; 26(3):145-58. PubMed ID: 12580645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of coding dictionary on signal generation: a consideration of use of MedDRA compared with WHO-ART.
    Brown EG
    Drug Saf; 2002; 25(6):445-52. PubMed ID: 12071782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OntoADR a semantic resource describing adverse drug reactions to support searching, coding, and information retrieval.
    Souvignet J; Declerck G; Asfari H; Jaulent MC; Bousquet C
    J Biomed Inform; 2016 Oct; 63():100-107. PubMed ID: 27369567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of automated signal generation in pharmacovigilance using a knowledge-based approach.
    Bousquet C; Henegar C; Louët AL; Degoulet P; Jaulent MC
    Int J Med Inform; 2005 Aug; 74(7-8):563-71. PubMed ID: 15955732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA.
    Wu L; Ingle T; Liu Z; Zhao-Wong A; Harris S; Thakkar S; Zhou G; Yang J; Xu J; Mehta D; Ge W; Tong W; Fang H
    BMC Bioinformatics; 2019 Mar; 20(Suppl 2):97. PubMed ID: 30871458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From narrative descriptions to MedDRA: automagically encoding adverse drug reactions.
    Combi C; Zorzi M; Pozzani G; Moretti U; Arzenton E
    J Biomed Inform; 2018 Aug; 84():184-199. PubMed ID: 29981491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of a medical dictionary for regulatory activities terminology (MedDRA) in prescription-event monitoring in Japan (J-PEM).
    Yokotsuka M; Aoyama M; Kubota K
    Int J Med Inform; 2000 Jul; 57(2-3):139-53. PubMed ID: 10961570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Language does not come "in boxes": Assessing discrepancies between adverse drug reactions spontaneous reporting and MedDRA® codes in European Portuguese.
    Inácio P; Airaksinen M; Cavaco A
    Res Social Adm Pharm; 2015; 11(5):664-74. PubMed ID: 25596069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Natural Language Processing (NLP) systems to annotate drug product labeling with MedDRA terminology.
    Ly T; Pamer C; Dang O; Brajovic S; Haider S; Botsis T; Milward D; Winter A; Lu S; Ball R
    J Biomed Inform; 2018 Jul; 83():73-86. PubMed ID: 29860093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semantic categories and relations for modelling adverse drug reactions towards a categorial structure for pharmacovigilance.
    Bousquet C; Trombert B; Kumar A; Rodrigues JM
    AMIA Annu Symp Proc; 2008 Nov; 2008():61-5. PubMed ID: 18998982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MedDRA and pharmacovigilance: a complex and little-evaluated tool.
    Prescrire Int; 2016 Oct; 25(175):247-250. PubMed ID: 30645835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping of the WHO-ART terminology on Snomed CT to improve grouping of related adverse drug reactions.
    Alecu I; Bousquet C; Mougin F; Jaulent MC
    Stud Health Technol Inform; 2006; 124():833-8. PubMed ID: 17108616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MedDRA® automated term groupings using OntoADR: evaluation with upper gastrointestinal bleedings.
    Souvignet J; Asfari H; Lardon J; Del Tedesco E; Declerck G; Bousquet C
    Expert Opin Drug Saf; 2016 Sep; 15(9):1153-61. PubMed ID: 27348725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ontological and Non-Ontological Resources for Associating Medical Dictionary for Regulatory Activities Terms to SNOMED Clinical Terms With Semantic Properties.
    Bousquet C; Souvignet J; Sadou É; Jaulent MC; Declerck G
    Front Pharmacol; 2019; 10():975. PubMed ID: 31551780
    [No Abstract]   [Full Text] [Related]  

  • 16. Building an ontology of adverse drug reactions for automated signal generation in pharmacovigilance.
    Henegar C; Bousquet C; Lillo-Le Louët A; Degoulet P; Jaulent MC
    Comput Biol Med; 2006; 36(7-8):748-67. PubMed ID: 16185681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semantic distance-based creation of clusters of pharmacovigilance terms and their evaluation.
    Dupuch M; Grabar N
    J Biomed Inform; 2015 Apr; 54():174-85. PubMed ID: 25659451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formalizing MedDRA to support semantic reasoning on adverse drug reaction terms.
    Bousquet C; Sadou É; Souvignet J; Jaulent MC; Declerck G
    J Biomed Inform; 2014 Jun; 49():282-91. PubMed ID: 24680984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case report: using SNOMED CT for grouping Adverse Drug Reactions Terms.
    Alecu I; Bousquet C; Jaulent MC
    BMC Med Inform Decis Mak; 2008 Oct; 8 Suppl 1(Suppl 1):S4. PubMed ID: 19007441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience using MedDRA for global events coding in HIV clinical trials.
    Tonéatti C; Saïdi Y; Meiffrédy V; Tangre P; Harel M; Eliette V; Dormont J; Pierre Aboulker J
    Contemp Clin Trials; 2006 Feb; 27(1):13-22. PubMed ID: 16288902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.